Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy

Clinical trial NCT01628627 · COMPLETED

Trial details

NCT number: NCT01628627
Sponsor: Lorenz Biotech S.p.A.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Neuropathy, Painful

Start date: 2006-05-01
Primary completion: 2010-04-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.